Cancer NetworkOriginal article
<![CDATA[Fractionated SRS Should Be Standard of Care After Brain Metastasis Surgery]]>
Data ReadoutpositivePositive
AI Analysis
Summary
Alliance A071801 trial results support fractionated stereotactic radiosurgery as standard of care following brain metastasis surgery, with comparable radiation necrosis rates to alternative approaches.
Clinical Trial Data
Primary Endpoint
Met
NCT ID
Outcome Details
Alliance A071801 trial supports fractionated stereotactic radiosurgery (SRS) as standard of care after brain metastasis surgery with comparable radiation necrosis rates
Importance:5/10
Sentiment:
0.70
oncologybrain metastasisradiation therapyclinical trialstandard of care
Related Companies
Read the original article
Published by Cancer Network on September 28, 2026 7:30 PM